{"id":105307,"date":"2020-04-14T08:45:30","date_gmt":"2020-04-14T15:45:30","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2020\/04\/adaptive-biotechs-deal-with-amgen-influenced"},"modified":"2020-04-18T00:46:12","modified_gmt":"2020-04-18T07:46:12","slug":"adaptive-biotechs-deal-with-amgen-influenced","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2020\/04\/adaptive-biotechs-deal-with-amgen-influenced","title":{"rendered":"Adaptive Biotech\u2019s deal with Amgen influenced by belief that COVID-19 may return seasonally, like flu"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/adaptive-biotechs-deal-with-amgen-influenced.jpg\"><\/a><\/p>\n<p>Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based company <a href=\"https:\/\/www.adaptivebiotech.com\/\">Adaptive Biotechnologies<\/a>.<\/p>\n<p>That\u2019s one of the reasons Adaptive is teaming up with pharmaceutical giant <a href=\"https:\/\/www.amgen.com\/\">Amgen,<\/a> which plans to use Adaptive\u2019s proprietary technology platform to develop therapies to treat the virus.<\/p>\n<p>Adaptive\u2019s <a href=\"https:\/\/www.adaptivebiotech.com\/about-us\/our-story\/chad-robins\/\">CEO Chad Robins<\/a> says it\u2019s the next big thing in the field of immune sequencing. They will screen blood samples of COVID-19 survivors, then identify which naturally occurring antibodies in the immune system can be used to neutralize the SARS-CoV-2 virus which causes the disease.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Despite a potential vaccine, the novel coronavirus could return on a seasonal basis, much like the flu, according to Seattle-based company Adaptive Biotechnologies. That\u2019s one of the reasons Adaptive is teaming up with pharmaceutical giant Amgen, which plans to use Adaptive\u2019s proprietary technology platform to develop therapies to treat the virus. Adaptive\u2019s CEO Chad Robins [\u2026]<\/p>\n","protected":false},"author":513,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-105307","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105307","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/513"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=105307"}],"version-history":[{"count":1,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105307\/revisions"}],"predecessor-version":[{"id":105632,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/105307\/revisions\/105632"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=105307"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=105307"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=105307"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}